| Items | Drug Registration information |
|---|---|
| ID | 2218 |
| No | 2218 |
| Brand Name | SEA-MOX TABLETS 400 MG |
| Ingredients | MOXIFLOXACIN (AS HYDROCHLORIDE) 400 MG |
| Dosage Form | TABLETS |
| Primary Packaging | ALU-ALU BLISTER |
| Storage | |
| Shelf Life | 2 YEARS |
| Pack Size | BOX OF 5'S |
| Dispensing Category | |
| ATC Classification | |
| Pharmaceutical Class | |
| Indications | INDICATED FOR TREATMENT OFTHE FOLLOWING BACTERIAL INFECTIONS IN PATIENTS OF 18 YEARS OF AGE AND OLDER CAUSED BY BACTERIA SUCEPTIBLE TO MOXIFLOXACIN: ACUTE BACTERIA SINUSITIS, ACUTE EXACERBATION OF CHRONIC BRONCHITIS, COMMUNITY ACQUIRED PNEUMONIA, EXCEPT SEVERE CASES, MILD TO MODERATE PELVIC INFLAMMATORY DISEASE, COMMUNITY-ACQUIRED PNEUMONIA, COMPLICATED SKIN AND SKIN STRUCTURE INFECTION |
| Contraindications | |
| Side Effects | |
| Unit Price | |
| EDL | NULL |
| Description | ORANGE COLOR, OVAL SHAPED, FILM COATED TABLET ENGRAVED SEARLE ON ONE SIDE AND BREAKLINE ON OTHER SIDE |
| Note | |
| License Owner | POUNSAB PHARMA CO.,LTD |
| Manufacturer | THE SEARLE COMPANY LIMITED |
| Country | PAKISTAN |
| Import Registration No | |
| Import Registration Date | |
| Activity | CERTIFICATE RELEASED |
| Applied Date | |
| FDD Registration No | 05 I 5534/23 |
| FDD Registration Date | 15/05/2023 |
| Expiry Date | 14/05/2026 |